Company / Depreciation & Amortization
Voyager Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$4.4M
FY2025
5-year range
$2.8M / $6.2M
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $5M to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +16.0%.
Improved from $5M to $4M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +16.0%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 28.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2024.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.4M | -28.3% |
| FY2024 | $6.2M | +19.9% |
| FY2023 | $5.2M | +35.3% |
| FY2022 | $3.8M | +38.0% |
| FY2021 | $2.8M | +30.6% |
| FY2020 | $2.1M | +32.7% |
| FY2019 | $1.6M | +160.6% |
| FY2018 | $612.0K | +2.0% |
| FY2017 | $600.0K | +226.1% |
| FY2016 | $184.0K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026